Category: Client Objectives

Client Objectives

New Microneedle Can Obliterate Spider Veins in One Sesson

A new microneedle device—the Given Needle—may help eradicate spider veins with one treatment, a new study shows.

Client Objectives

FDA Approves Restylane Lyft for Chin Augmentation

Pivotal trial data showed sustained improvement in chin projection and high patient and investigator satisfaction through 12 months.

Client Objectives

FDA Warns of Serious Complications with Certain RF Microneedling Devices

The agency has received reports of burns, scarring, fat loss, and nerve damage associated with the aesthetic devices and is urging providers to report adverse events.

Aesthetics

A New Era for Fat-Based Injectables in Body Contouring

A new fat-based injectable is reshaping non-surgical body contouring. Plastic Surgery Practice examines the science and clinical adoption of alloClae with Tiger Aesthetics President Caroline Van Hove and Dr David Shafer.

Dermatology

Phase 3 Trial Shows Positive Results for Oral Acne Drug Denifanstat

The once-daily FASN inhibitor met all primary and secondary endpoints for treating moderate to severe acne, with data to be presented at the EADV Congress.

Rejuvenation

New Studies Highlight Injectable Advances in Chin Augmentation, Weight Loss–Related Volume Loss, and Neuromodulators

Data on a hyaluronic acid filler for chin shaping, a biostimulator for medication-driven weight loss effects, and a liquid neuromodulator will be presented at the upcoming AMWC Dubai.